Sinopharm eyes new $200m offshore borrowing
Sinopharm Holding China Finance Leasing, a unit of state-owned China National Pharmaceutical Group, is tapping offshore banks for a $200m term loan.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: